Top 50 Biotech Startup Investors in Japan (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Mitsubishi UFJ Capital
VC Fund
|
20 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $2M–$369M |
|
UntroD Capital
VC Fund
|
18 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Medical | $2.1M–$241M |
|
Fast Track Initiative, Inc.
VC Fund
|
16 | Japan, United States, United Kingdom | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $1.1M–$184M |
|
Osaka University Venture Capital
VC Fund
|
16 | Japan | Seed, Series A | Biotechnology, Health Care, Manufacturing | $7.1M–$142M |
|
SMBC Venture Capital
VC Fund
|
16 | Japan, United States, Singapore | Series A, Series B | Information Technology, Health Care, Software | $4.5M–$425M |
|
ANRI
VC Fund
|
15 | Japan, United States, India | Seed, Series A | Software, Health Care, Information Technology | $628k–$624M |
|
Keio Innovation Initiative
VC Fund
|
12 | Japan, United Kingdom | Series A, Seed | Health Care, Medical, Biotechnology | $1.5M–$213M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
12 | Japan, United States, India | Seed, Series A | Health Care, Biotechnology, Medical | $3.1M–$85M |
|
JAFCO
VC Fund
|
11 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $2.7M–$298M |
|
Mizuho Capital
VC Fund
|
10 | Japan, United States, China | Series A, Series B | Information Technology, Software, Internet | $2.7M–$553M |
|
Real Tech Japan
VC Fund
|
9 | Japan, Singapore, Austria | Series A, Seed | Manufacturing, Biotechnology, Medical | $5M–$241M |
|
SBI Investment
VC Fund
|
9 | Japan, South Korea, United States | Series B, Series A | Information Technology, Software, Financial Services | $4M–$283M |
|
Miyako Capital
VC Fund
|
8 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $5.6M–$3B |
|
DBJ Capital
VC Fund
|
7 | Japan, United States, Australia | Series A, Series B | Software, Medical, Health Care | $4M–$510M |
|
Nissay Capital
VC Fund
|
7 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $709k–$71M |
|
Japan Science and Technology Agency
VC Fund
|
7 | Japan | Series A, Seed | Medical, Biotechnology, Manufacturing | $1.7M–$255M |
|
Nippon Venture Capital
VC Fund
|
6 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Medical | $3M–$269M |
|
Miraidoa
VC Fund
|
6 | Japan, United States, Myanmar | Seed, Series A | Health Care, Manufacturing, Information Technology | $933k–$125M |
|
Incubate Fund
VC Fund
|
6 | Japan, United States, India | Seed, Series A | Software, Information Technology, E-Commerce | $362k–$113M |
|
DG Daiwa Ventures
VC Fund
|
5 | Japan, United States, India | Seed, Series A | FinTech, Software, Internet | $679k–$142M |
|
Senshu Ikeda Capital
VC Fund
|
5 | Japan | Series A, Seed | Software, Manufacturing, Internet | $1M–$142M |
|
FFG Venture Business Partners
VC Fund
|
5 | Japan, Indonesia, United States | Series A, Seed | Software, Health Care, Artificial Intelligence | $1.2M–$113M |
|
F-Prime
VC Fund
|
4 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $9.2M–$130M |
|
D3
VC Fund
|
4 | Japan, United States | Series A, Seed, Series B | Medical, Software, Therapeutics | $1.5M–$170M |
|
Remiges Ventures
VC Fund
|
4 | United States, Japan, Canada | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $8.1M–$553M |
|
Fujifilm
VC Fund
|
4 | Japan, United States, China | Series A, Corporate Round | Biotechnology, Health Care, Medical | $1.3M–$1.7B |
|
Angel Bridge
VC Fund
|
4 | Japan | Series A, Seed | Information Technology, Software, Consulting | $746k–$170M |
|
Tsukuba Institute of Research
VC Fund
|
3 | Japan | Series A, Seed | Medical, Biotechnology, Manufacturing | $31M–$122M |
|
Antler
VC Fund
|
3 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $104k–$29M |
|
KSP
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Delight Ventures
VC Fund
|
3 | Japan, United States, South Korea | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $429k–$500M |
|
Tohoku University Venture Partners
VC Fund
|
3 | Japan | Series A, Seed, Series B | Medical, Manufacturing, Health Care | $349k–$122M |
|
WASEDA University Ventures
VC Fund
|
3 | Japan, United States | Series A, Seed, Convertible Note | Biotechnology, Information Technology, Medical | $1.2M–$75M |
|
Chushin Venture Capital
VC Fund
|
3 | Japan | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $955k–$128M |
|
Eight Roads Ventures
VC Fund
|
3 | United States, China, India | Series B, Series A, Series C | Software, Health Care, Biotechnology | $6.4M–$113M |
|
Higin Capital
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Medical, Software | $1.9M–$184M |
|
Kyogin Lease & Capital
VC Fund
|
3 | Japan | Series A, Series B | Medical, Manufacturing, Task Management | $6.1M–$340M |
|
Takeda
VC Fund
|
3 | United States, Japan, China | Grant, Corporate Round | Biotechnology, Health Care, Pharmaceutical | $5k–$1.4B |
|
JIC Venture Growth Investments
VC Fund
|
3 | Japan, Singapore, United States | Series B, Series C | Information Technology, Software, Medical | $7.3M–$567M |
|
Takeda Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Capital Medica Ventures
VC Fund
|
3 | Japan | Seed, Series A | Medical, Health Care, Software | $403k–$50M |
|
Sosei CVC
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Medical, Pharmaceutical | |
|
Ohara Pharmaceutical
VC Fund
|
2 | Japan, Kenya, Nigeria | Series A, Series B | Medical, Biotechnology, Software | $10M–$184M |
|
Japan Asia Investment
VC Fund
|
2 | Japan, United States, China | Series B, Series C | Medical, Biotechnology, Health Care | $5M–$283M |
|
QB Capital
VC Fund
|
2 | Japan, Singapore, United States | Seed, Series A | Manufacturing, Medical, Biotechnology | |
|
Koki Yabu
Angel
|
2 | Japan | Angel, Pre-Seed | Content, Finance, Data Mining | |
|
Spiral Capital
VC Fund
|
2 | Japan, United Kingdom | Series A, Series B | Software, Information Technology, Internet | |
|
Primal Capital
VC Fund
|
2 | Japan, Spain, Switzerland | Seed, Pre-Seed | Software, Information Technology, Internet | |
|
Cosmo Bio
VC Fund
|
2 | Japan | Seed | Medical, Biotechnology, Pharmaceutical | |
|
Innovation Network Corporation of Japan
VC Fund
|
2 | Japan, United States, United Kingdom | Series B, Series A | Manufacturing, Software, Robotics | |
| Access all 518 investors in Japan Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 501
- Round size: Series A $2M–$113M; Series B $5.7M–$369M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Japan Culture and Technology — Japan Culture and Technology assists artists and craftspeople in expanding their activities by providing IT support.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 124
- Round size: Seed $3.2M–$43M; Series A $2.1M–$241M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
- Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 77
- Round size: Seed $1.2M–$117M; Series A $1.1M–$142M; Series B $7.7M–$184M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2021
Portfolio highlights
- Global Vascular —
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 79
- Round size: Seed $7.1M–$99M; Series A $16M–$142M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 513
- Round size: Series A $4.5M–$170M; Series B $5.7M–$425M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Letara — Letara operates a space technology platform with the intention to serve a logistics network covering the solar system. The company produces hybrid propulsion engines for small spacecraft, promoting groundbreaking advances in space propulsion with high thrust, safe, and inexpensive propulsion system technology.
- Pragtech — Pragtech develops and operates parking lot service software that helps to eliminate payment congestion and reduce operating costs.
- Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 240
- Round size: Seed $628k–$92M; Series A $6.1M–$624M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
- Chaintope — Chaintope is specializes in blockchain technology with a focus for FinTech and non-FinTech sectors.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $1.5M–$213M; Series A $7.4M–$155M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 175
- Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
- Metcela — Cells hold endless possibilities. Through science, we will unlock these potentials and harness them to improve the lives of patients worldwide.
- Startbahn — Startbahn develops Startrail, a sustainable and scalable blockchain infrastructure that assures the reliability, authenticity, and traceability of artworks.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 271
- Round size: Series A $2.7M–$255M; Series B $6.4M–$298M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Plott — Plott producing youtube animation platform under Vision “Become a Content holder from YouTube”. In August 2019, the company name was changed from Fabo to Plott. Plott, the new company name, is derived from the plot that you make before writing novels, etc., and the idea that “I want to make content all the time” is put in the company name.
- Sharing Energy — Sharing Energy is providing energy supply and energy management services.
- The Chain Museum — The Chain Museum creates a platform for connecting individuals .
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Series A, Series B
- Geography: Japan, United States, China
Investor stats
- Total investments: 439
- Round size: Series A $2.7M–$156M; Series B $5.2M–$553M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Logiless — Logiless is a cloud type all-in-one software dedicated to net shop. Since both orders and stocks can be managed together in a logical manner, efficiency of operations can be realized at low cost.
- LUC — LUC is a provider of the AI x experience analysis platform "TERUS," .
- Turing — Turing develops and manufactures fully autonomous vehicles.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Series A, Seed
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $5M–$43M; Series A $6M–$241M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Information Technology, Software, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 350
- Round size: Series A $4M–$170M; Series B $6.5M–$283M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $5.6M–$118M; Series A $6.1M–$70M; Series B $99M–$3B
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- VLP Therapeutics — VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary nextgeneration i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland
- XFOREST Therapeutics — xFOREST Therapeutics develops a drug discovery platform that targets RNA structures.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Australia
Investor stats
- Total investments: 150
- Round size: Series A $4M–$283M; Series B $6.9M–$510M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Linqmed — Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
- Simple Form — Simple Form provides real-time information on all domestic corporations necessary for financial institutions. We will accelerate the time-consuming and labor-intensive research work of corporations and take on the role of new financial underpinnings.
- Japan Culture and Technology — Japan Culture and Technology assists artists and craftspeople in expanding their activities by providing IT support.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 239
- Round size: Seed $709k–$43M; Series A $2.7M–$71M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Menou — MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software.
- Castee — Castee provides social collaboration services and also helps with a tool for job requests and overseas projects for creators.
- 3S — 3S is a SaaS developer platform that provides and operates 24-hour home nursing care services through technology.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 44
- Round size: Seed $1.7M–$50M; Series A $3.1M–$255M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- OptQC — OptQC commercializes cutting-edge optical quantum computing technologies developed by the Furusawa-Endo Laboratory. Because optical quantum computers are more scalable than superconducting and other quantum computing implementations, OptQC's optical quantum computers should reach this scale. They also have benefits like faster processing andreduced power consumption, which makes optical quantum computers a possible long-term pinnacle of quantum technology.
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 163
- Round size: Series A $3M–$85M; Series B $7.7M–$269M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Gecipe — Gecipe is a video service for e-sports players.
- Issues — Issues provides development and management of web service issues that solve the problems.
- SecureNavi — SecureNavi offers automation tools for the information security management system. It reduces conventional analogue operations using excel and word. For inquiries, telephone numbers and physical addresses are available on their website.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Japan, United States, Myanmar
Investor stats
- Total investments: 145
- Round size: Seed $933k–$33M; Series A $2.5M–$125M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $36M in 2020
Portfolio highlights
- Yadokari — Yadokari provides various types of Construction & Real Estate related other services.
- FullDepth — FullDepth is a drone development company.
- Peco Free — Peco Free is a school meal pre-order service that is selected using a smartphone.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 279
- Round size: Seed $362k–$48M; Series A $2.8M–$113M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $2.4B in 2021
Portfolio highlights
- Paytner — yup is providing services to support freelance people's funding.The freelance population in Japan has been shown to continue to increase in many Chosa. While working styles are diversified, they are not able to respond to the development of the working environment, and they will develop their business to change the situation where problemssuch as funding, credit, sexual harassment, and power harassment are accumulated.
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Black Cat Carnival Inc. is a communication service development company.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: FinTech, Software, Internet
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 71
- Round size: Seed $679k–$26M; Series A $4M–$142M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Fivot — Fivot is a financial company that provides venture capital, financing, credit, money lending, and prepaid payment services.
- digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- Zehitomo — Zehitomo is an Japanese online platform that enables user to hire local service professionals, from photographers to personal trainers.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $1M–$61M; Series A $1.9M–$142M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $177M in 2019
Portfolio highlights
- TSK Corporation —
- Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.
- New Innovations — New Innovations company is offering a snuggling service to many people who support Japan's “high quality”. AI and robots do not take away the job, but robots support the work that is accomplished without the involvement of people, and many working people are aiming for the future to create a more humanoid life. With the problem of lack oftalent, it was difficult to reflect technology on OFF Line until now, trying to provide robots in the “food and drink” and “retail” industry, CEKAI's first demand forecast AI unmanned cafeThe robot “√C” was developed. √C is not “looking for coffee that suits me”, but instead realizes “coffee is perfect for me” with demand forecasting AI. Today, people who drink coffee are choosing their favorite cafe, canned coffee, convenience store coffee, etc., according to their taste needs, SPEED needs, and hospitality needs. The company developed the service as a new choice of coffee, and in the future, the perfect coffee according to the taste preferences, busy, physical condition and mood of the day., which aims to provide. In July 2019, the company receives a third party quota increase of 70 million yen from Zashid Capital and DEEPCORE. From August 1, 2019, with the cooperation of Nankai Electric Railway, “√C” will be installed at Namba Station/Namba Skyo, and demonstration experiments will begin.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Japan, Indonesia, United States
Investor stats
- Total investments: 77
- Round size: Seed $5.7M–$69M; Series A $1.2M–$113M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $691M in 2020
Portfolio highlights
- Josan-shes — Josan shes is web start up that offers nursing service to women and babies.
- ACCEL Stars — ACCEL Stars is a fitness and wellness firm that offers sleep diagnosis and examinations like sleep health, hygiene and medical devices.
- Cellid — Cellid developing the waveguide-architecture display module for AR glasses and high-performance spatial recognition software.
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 423
- Round size: Series A $9.2M–$87M; Series B $16M–$130M; Series C $22M–$115M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Axle Health — Axle Health provides scheduling and workforce management software to help home healthcare and hospice providers improve their clinician productivity.
- CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
- RightHand Robotics — RightHand Robotics offers advanced robotic piece-picking technology for efficient and predictable order fulfillment. Contact us today to learn how.
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Show more...Investment focus
- Industry: Medical, Software, Therapeutics
- Stage:Series A, Seed, Series B
- Geography: Japan, United States
Investor stats
- Total investments: 10
- Round size: Series A $1.5M–$170M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Neumo — Neumo is a musical education-based firm that offers pitch measurement courses, programs, consulting, and tests.
- RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
- Neros Technologies — Neros is vertically integrating production of unmanned defense systems in the United States, securing the autonomous supply chain. Are you with us?
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 24
- Round size: Seed $10M–$42M; Series A $8.1M–$85M; Series B $8.2M–$553M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $95M in 2019
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Corporate Round
- Geography: Japan, United States, China
Investor stats
- Total investments: 25
- Round size: Series A $15M–$425M; Corporate Round $1.3M–$1.7B
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ripcord — Ripcord is a robotics company that combines hardware and software robotics via an integrated SaaS offering. Its focus is on smart robotics digitization, smart content management with AI, and helping enable RPA and business processes.Ripcord is based in Hayward, California, and is backed by leading investors Kleiner Perkins Caufield & Byers,Google Ventures, Lux Ventures, Legend Star, and Apple Co-Founder Steve Wozniak.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $2.2M–$113M; Series A $746k–$170M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Fivot — Fivot is a financial company that provides venture capital, financing, credit, money lending, and prepaid payment services.
- Plainer — Plainer is an IT company that provides software development, data management, and SaaS solutions.
- CraftBank — CraftBank, Inc. is the start-up that operates online matching platform between constructors with having relations with 22k specialty constructors (10% coverage in the market). The company was succeeded in Management BuyOut in April 2021.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 7
- Round size: Series A $31M–$122M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- Veneno Technologies — Veneno Technologies engages in the research and development of therapeutic disulfide-rich peptides and contribute to advanced medicine.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1204
- Round size: Seed $196k–$5.8M; Pre-Seed $104k–$1.1M; Series A $4.6M–$29M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Sapyen — We take the fear out of infertility for men. Test for it at home, without stepping out to the hospital and get personalised health recommendations to improve sperm health and increase your chances of conceiving.
- Superflex — Elevate your workflow with Superflex, the ultimate Figma-to-code solution. Our AI instantly converts Figma and Image designs into pixel-perfect, production-ready code that meets your standards and boosts team efficiency.
- One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- Mira Robotics — Mira Robotics is a software based company provide services that can robots in various fields.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Delight Ventures is a venture capital firm that thoroughly reduces the hurdles of entrepreneurship in Japan and supports entrepreneurs in the world. Entrepreneurship is taken as a natural career path, and we aim to be a society where both successful and unsuccessful people can continue to take on challenges.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, South Korea
Investor stats
- Total investments: 77
- Round size: Seed $697k–$64M; Series A $6M–$500M; Series B $429k–$312M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- CUSTA —
- YOUTRUST — YOUTRUST is a startup to operate YOUTRUST a referral recruitment platform for side-job change.
- Josh Collaboration — Josh Collaboration is a software company that provides mailing, fax transmission, and partner management services.
THVP is a venture capital corporation for startup innovation. It was established in 2015 and is based in Nagoya, Japan.
Show more...Investment focus
- Industry: Medical, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 23
- Round size: Seed $14M–$44M; Series A $349k–$122M; Series B $7.5M–$85M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Koeda — KOEDA is researching and developing medical devices that are safe, painless, and easy to use for acute cholecystitis. KOEDA will transform the management of cholecystitis. So far, endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has been a notably difficult procedure carried out by skilled doctors at specific advanced centers. Althoughinserting a tube into the gallbladder is less invasive, it is complex, and there may be concerns regarding bile leakage. By combining clinical expertise with precision engineering, KOEDA addresses a clearly defined medical need in a growing global market and is currently moving forward on schedule for regulatory clearance and commercialization.
- AI Silk — AI Silk are innovative conductive fibers produced with a dyeing technique. By using natural silk and giving conductivity to the fiber itself, They have succeeded in producing electrodes that reduce some of the risks and challenges of conventional medical electrodes, which can cause discomfort,skin and in vivo inflammation, and measurement failuredue to sweat or other elements. Their brand, AI Silk, is a new material that has strong and diverse application potential, even beyond the health / medical field.
- ElevationSpace — ElevationSpace offers high quality & well equipped workspaces giving tenants a nurturing environment .
WASEDA University Ventures (WUV) is a venture capital firm specialising in founding investments by creating new start-up companies that make use of academia and are based on "the practical application of scholarship". Our mission is to be a capitalist that implements academic knowledge and
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Medical
- Stage:Series A, Seed, Convertible Note
- Geography: Japan, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.2M–$38M; Series A $1.3M–$75M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Pestalozzi Technology — Pestalozzi Technology is a development and provision of educational products in the fields of physical education and club activities.
- Gel-Coat Biomaterials — Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
- CoreTissue BioEngineering — CoreTissue BioEngineering is a development of an artificial ligament for reconstruction of the anterior cruciate ligament in Japan.
Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 11
- Round size: Seed $1.5M–$2M; Series A $955k–$128M; Series B $5.1M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nexta — Nexta manufactures site, issues such as analog management, personalization of operations & labor shortages are becoming more serious.
- OOYOO — OOYOO Co., Ltd. is a DeepTech venture that combines international entrepreneurial spirit, and a 'Made In Japan' excellence, to bring the latest innovations in clean technology to society for a smarter, cleaner, and more mobile world.
- DeepForest Technologies — DeepForest Technologies is an IT firm that offers drone photography, forest information analysis, DF Scanner, and data processing services.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 355
- Round size: Series A $6.4M–$62M; Series B $8M–$85M; Series C $13M–$113M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- LeadIQ — LeadIQ makes sales teams more efficient at outbound prospecting by capturing and sequencing contact information with one click.
- Stockpile — Give gift cards for stock this holiday season
- Metcela — Cells hold endless possibilities. Through science, we will unlock these potentials and harness them to improve the lives of patients worldwide.
Higegin Capital is a venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 22
- Round size: Series A $1.9M–$184M; Series B $3.8M–$170M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $137M in 2020
Portfolio highlights
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- Photo Electron Soul — Photo electron Soul mission is to innovate the world of "seeing (fine observation)" and "creating (fine processing)" through the development of photocathode electron beam technology. The photocathode electron beam technology developed by our company will produce next generation electron beams with high performance andversatility (pulse structure, low dispersion, large current). By renewing the electron beam, which is a key device for industrial equipment such as electron microscopes, semiconductor device manufacturing / inspection equipment, and metal 3D printers, it is possible to realize fine observation, fine processing, high throughput, etc. Breakthroughs in a wide range of fields such as science, materials, and electronics.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more...Investment focus
- Industry: Medical, Manufacturing, Task Management
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 28
- Round size: Series A $6.1M–$57M; Series B $38M–$340M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KOMPEITO — Office de Yasai is an online platform that enables users to order and get vegetables delivered to their offices. The platform’s operations are based in Tokyo, Japan.
- Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
- Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Grant, Corporate Round
- Geography: United States, Japan, China
Investor stats
- Total investments: 56
- Round size: Grant $5k–$35k; Corporate Round $52M–$1.4B
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- BaseLaunch — We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures, developing cutting-edge therapeutics.
- Beacon Biosignals — AI + EEG to change the way patients are treated for disorders of the brain.
- Innovent Biologics — Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Show more...Investment focus
- Industry: Information Technology, Software, Medical
- Stage:Series B, Series C
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 86
- Round size: Series B $7.3M–$567M; Series C $11M–$411M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- KOMPEITO — Office de Yasai is an online platform that enables users to order and get vegetables delivered to their offices. The platform’s operations are based in Tokyo, Japan.
- FLUX — FLUX provide “FLUX Header Bidding Solution” that creates fair competition opportunities and significantly increases advertising revenue within the header bidding server, ad requests are sent to SSPs and ad exchanges all at once, so it is possible to have a pure price competition without prioritization, and to determine the highest bid amount andvalue of the advertising space. I can. Then, the price of the highest bid ad in the header bidding and the ad set in the ad server are competed, and the ad with the higher bid is delivered.
- Turing — Turing develops and manufactures fully autonomous vehicles.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- StrideBio — StrideBio is a gene therapy company focused on developing genetic medicines with curative potential for patients with devastating conditions. It leverages its proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes toovercome current limitations of first-generation gene therapies. The company was founded in 2015 and is headquartered in Durham, North Carolina.
- Xilio Therapeutics — WhatsApp Group Invite
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Industry: Medical, Health Care, Software
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 12
- Round size: Seed $403k–$17M; Series A $15M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- A-SEEDS — A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
- AMI — AMI Corp is engaged in medical consulting, medical device development and writing.
- Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
Sosei CVC is support the creation and growth of life science companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products.
Show more...Investment focus
- Industry: Medical, Biotechnology, Software
- Stage:Series A, Series B
- Geography: Japan, Kenya, Nigeria
Investor stats
- Total investments: 10
- Round size: Series A $10M–$78M; Series B $30M–$184M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Mydawa — MYDAWA is here to ensure that every Kenyan can get quality, secure and affordable medicine and wellness products online
- Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
- Revital Healthcare — Revital Healthcare is a manufacturer of medical devices and disposables for hospitals and other medical laboratories. It offers single-use syringes, needles, re-use prevention syringes and auto-disable syringes which helps in reducing the transmission of HIV and other blood-borne diseases along with infusion sets, blood transfusion sets and bloodcollection tubesThe company was established in 2006 and is headquartered in Kilifi, Kenya.
JAIC is Japan's largest independent venture capital firm and has accumulated experience and know-how over a period of 15 years as a pioneer of venture capital investments in Asia. Building on such strengths, they are establishing a globally linked organization that pursues investment opportunities centering on the three regions of Japan, Asia,and the United States.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Series B, Series C
- Geography: Japan, United States, China
Investor stats
- Total investments: 35
- Round size: Series B $6M–$283M; Series C $5M–$32M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- FacePeer — FacePeer is looking for people who want to challenge at startup.
- REGiMMUNE — REGiMMUNE Corporation is a private biopharmaceutical company developing innovative solutions for treating immune disorders caused by nonspecific and/or excessive immune reactions. REGiMMUNE uses its proprietary technology platform, reVax (reverse vaccination), to target immune tolerance against specific disease-causing antigens throughinduction of regulatory T cells (Treg). This technology has potential applications in a number of immune system disorders and diseases including Graft versus Host Disease (GvHD), type 1 diabetes mellitus (T1DM), rheumatoid arthritis (RA), multiple sclerosis (MS) and systemic lupus erythematosus (SLE).Currently, the company has one clinical-stage compound in a Phase I/II trial in the United States (RGI-2001) as a treatment for GvHD associated with hematopoietic stem cell transplantation and has a second product in preclinical development (RGI-3001) as a new treatment for T1DM. In addition, it has a number of well-differentiated compounds in its research-stage pipeline.In healthy individuals, the normal immune system works to protect humans from disease-causing viruses, bacterium, and cancers; or foreign antigens such as peanuts, wheat and tree pollens. Conventional immunosuppressants have several significant side effects associated with long-term administration including risk of infection, toxicity and relapse. Products developed with ReVax technology are expected to reduce or eliminate such side effects as well as reduce long-term treatment.
- Integral Geometry Science — Integral Geometry Science is a specialized manufacturer of measuring equipment and signal / image processing software.
QB Capital is make equity investments in venture companies.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Seed, Series A
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 49
- Lead/follow: no public data
Portfolio highlights
- Alumnote — The alumni association management software developed by Alumnote allows schools to manage their alumni associations online. The focus of the company is to undertake loyalty building and marketing for potential donors such as graduates and provides digital tools, and supports the execution of donation acquisition.
- Equmenopolis — Equmenopolis is an information services company that specializes in conversational AI agent platforms and application developments.
- Mechano Cross — Mechano Cross is a mechanical company that offers mechanochemical organic synthesis technology for solution reactions.
Koki Yabu is Founder, President & CEO at Mobcast inc.
Show more...Investment focus
- Industry: Content, Finance, Data Mining
- Stage:Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Mobcast group — mobcast is a sports entertainment company that operates a mobile entertainment platform for smartphones and feature phones. It supports customers with social game and social media services. The company was founded in 2009 and is based in Tokyo, Japan. Currently, it operates as a subsidiary of mobcast Inc.
- SmartApp Japan — Smart Apps is a developer of a blockchain services application designed for smartphones. The company's application uses cryptocurrency technology to offer token issuance, initial coin offering and dApps design support, providing a launchpad for start-up blockchain-related businesses.
Spiral Capital is a venture capital fund.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Series A, Series B
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 86
- Lead/follow: no public data
Portfolio highlights
- MUSE — MUSE is a robotics company that provides robotic solutions for retail stores to support in-store operations.
- Turing — Turing develops and manufactures fully autonomous vehicles.
- BACKSEAT — BACKSEAT provides embedded crypto exchange and Web3 Services.
Primal Capital, an independent venture capital " incubator bait fund at ", served as the Associate than July 2012 Hiroshi was Sasaki is the venture capital fund that serves as the representative partner. Representative of Sasaki, the seed acceleration program "Incubate Camp" operated by Incubate bait fund is carried out a totalof four times of planning and management than in 2012, They have also engaged in support operations of portfolio companies. - See more at: https://www.crunchbase.com/organization/primal-capital#sthash.m2z1DCbt.dpuf
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Pre-Seed
- Geography: Japan, Spain, Switzerland
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Hivello — Hivello is a Decentralized Physical Infrastructure Network aggregator. Contribute resources, connect with Web3 protocols, and effortlessly generate passive income.
- RemitAid — RemitAid is a fintech company that operates an overseas payment platform for cross-border transactions between companies.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Cosmo Bio provides the most up-to-date products and technical information available from world-class manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout Japan and around the world. They are proud that their ability to supply a vast array of products and information allows us to serve theneeds of all of their customers. By making full use of their international network, coupled with the highest quality information, they support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Fimecs — FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
- Lab Biotech — Lab Biotech manufactures, conducts research, devises plans, and consults with pharmaceutical and food manufacturers.
Innovation Network Corporation of Japan (INCJ) is a public-private partnership aimed at promoting innovation and enhancing value.Leveraging the rich history of Japanese technological prowess, INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through “openinnovation,” or the flow of technology and expertise beyond the boundaries of existing organizational structures.INCJ will draw on funding as well as management and technological expertise from the public and private sectors. INCJ is actively reviewing various investment opportunities in areas of green energy, electronics, IT and biotechnology to infrastructure-related sectors such as water supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of INCJ's Innovation Network Committee, which will make the final investment decisions.INCJ is capitalized at 280 billion yen, with the Japanese government injecting 266 billion yen and 26 private corporations (refer to details in Appendix below) providing a further 14 billion yen. The government will also provide guarantees up to a total of 1,800 billion yen for INCJ investments, giving it an investment capability of approximately 2,000 billion yen. INCJ will be established for a period of 15 years.
Show more...Investment focus
- Industry: Manufacturing, Software, Robotics
- Stage:Series B, Series A
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 123
- Lead/follow: no public data
Portfolio highlights
- Cloudian — Cloudian provides exabyte-scale storage for your capacity-intensive workloads: S3-compatible storage for on-prem, hybrid cloud, and multi-cloud.
- Seajacks — Cadeler is a global leader in offshore wind farm construction, maintenance, and decommissioning.
- Vehicle Energy Japan — Vehicle Energy Japan specializes in development, manufacturing and sales of automotive lithium-ion batteries.
Biotech Investor funding in Japan at a glance
Stats across 434 deals from 518 investors.
Access all 518 investors in Japan Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 518 investors investing in Japan Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!